Question 1

What is the catalog number for Tissue FFPE Sections, Endometrium?

Accepted Answer

The catalog number for Tissue FFPE Sections, Endometrium is CS802543.

Question 2

What sizes are available for Tissue FFPE Sections, Endometrium?

Accepted Answer

Tissue FFPE Sections, Endometrium is available in the following size(s): 5x 5 µm.

Question 3

Is Tissue FFPE Sections, Endometrium in stock?

Accepted Answer

Tissue FFPE Sections, Endometrium is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue FFPE Sections, Endometrium?

Accepted Answer

The safety data sheet for Tissue FFPE Sections, Endometrium is available here: https://cdn.origene.com/sds/cs802543.pdf.

Question 5

What is Tissue FFPE Sections, Endometrium used for?

Accepted Answer

Tissue Sections (5x5um), FFPE; Endometrium; Adenocarcinoma of endometrium, endometrioid

Question 6

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 7

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 8

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Tissue FFPE Sections, Endometrium

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

2-Amino-4-thiazoleacetic Acid

CD40 / TNFRSF5 / CD40L-Receptor (T8P2G4*A6), CF640R conjugate, 0.1mg/mL

NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (NX2/1422R), 0.2mg/mL

IL3RA / CD123 (Acute Myeloid Leukemia Marker) (IL3RA/2065), Biotin conjugate, 0.1mg/mL

Ponatinib

Malonic Acid